CHEMED CORP (CHE) Fundamental Analysis & Valuation

NYSE:CHE • US16359R1032

Current stock price

422.72 USD
+1.61 (+0.38%)
At close:
422.72 USD
0 (0%)
After Hours:

This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CHE Profitability Analysis

1.1 Basic Checks

  • In the past year CHE was profitable.
  • In the past year CHE had a positive cash flow from operations.
  • CHE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CHE had a positive operating cash flow.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • The Return On Assets of CHE (16.91%) is better than 100.00% of its industry peers.
  • CHE's Return On Equity of 30.64% is amongst the best of the industry. CHE outperforms 95.00% of its industry peers.
  • CHE has a better Return On Invested Capital (21.50%) than 96.00% of its industry peers.
  • CHE had an Average Return On Invested Capital over the past 3 years of 21.04%. This is significantly above the industry average of 8.40%.
  • The last Return On Invested Capital (21.50%) for CHE is above the 3 year average (21.04%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.91%
ROE 30.64%
ROIC 21.5%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • The Profit Margin of CHE (10.23%) is better than 97.00% of its industry peers.
  • CHE's Profit Margin has declined in the last couple of years.
  • CHE's Operating Margin of 13.69% is amongst the best of the industry. CHE outperforms 87.00% of its industry peers.
  • CHE's Operating Margin has declined in the last couple of years.
  • CHE has a better Gross Margin (32.38%) than 65.00% of its industry peers.
  • CHE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.69%
PM (TTM) 10.23%
GM 32.38%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

7

2. CHE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHE is creating value.
  • CHE has less shares outstanding than it did 1 year ago.
  • CHE has less shares outstanding than it did 5 years ago.
  • CHE has a worse debt/assets ratio than last year.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • CHE has an Altman-Z score of 10.50. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
  • CHE's Altman-Z score of 10.50 is amongst the best of the industry. CHE outperforms 95.00% of its industry peers.
  • The Debt to FCF ratio of CHE is 0.24, which is an excellent value as it means it would take CHE, only 0.24 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.24, CHE belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
  • CHE has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.11, CHE is doing good in the industry, outperforming 76.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.24
Altman-Z 10.5
ROIC/WACC2.4
WACC8.96%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • CHE has a Current Ratio of 0.85. This is a bad value and indicates that CHE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.85, CHE is doing worse than 80.00% of the companies in the same industry.
  • A Quick Ratio of 0.83 indicates that CHE may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.83, CHE is doing worse than 75.00% of the companies in the same industry.
  • CHE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.83
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

4

3. CHE Growth Analysis

3.1 Past

  • CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.32%.
  • CHE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.61% yearly.
  • CHE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.07%.
  • Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.00% on average per year.
EPS 1Y (TTM)-8.32%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%0.36%
Revenue 1Y (TTM)2.07%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%1.63%

3.2 Future

  • CHE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.57% yearly.
  • Based on estimates for the next years, CHE will show a small growth in Revenue. The Revenue will grow by 5.67% on average per year.
EPS Next Y11.69%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20 25

5

4. CHE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 19.56, which indicates a rather expensive current valuation of CHE.
  • Compared to the rest of the industry, the Price/Earnings ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 71.00% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.15. CHE is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 15.72 indicates a correct valuation of CHE.
  • 72.00% of the companies in the same industry are more expensive than CHE, based on the Price/Forward Earnings ratio.
  • CHE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.56
Fwd PE 15.72
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • CHE's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 72.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.38
EV/EBITDA 15.12
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.67
PEG (5Y)5.42
EPS Next 2Y11.6%
EPS Next 3Y10.57%

6

5. CHE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.57%, CHE is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.46, CHE pays a better dividend. On top of this CHE pays more dividend than 81.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CHE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.57%

5.2 History

  • On average, the dividend of CHE grows each year by 11.06%, which is quite nice.
  • CHE has paid a dividend for at least 10 years, which is a reliable track record.
  • CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.06%
Div Incr Years17
Div Non Decr Years22
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CHE pays out 12.53% of its income as dividend. This is a sustainable payout ratio.
  • CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP12.53%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

CHE Fundamentals: All Metrics, Ratios and Statistics

CHEMED CORP

NYSE:CHE (4/27/2026, 8:04:00 PM)

After market: 422.72 0 (0%)

422.72

+1.61 (+0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-23
Earnings (Next)07-27
Inst Owners104.27%
Inst Owner Change0.07%
Ins Owners1.51%
Ins Owner Change-1.34%
Market Cap6.18B
Revenue(TTM)2.54B
Net Income(TTM)259.78M
Analysts75
Price Target451.86 (6.89%)
Short Float %3%
Short Ratio1.56
Dividend
Industry RankSector Rank
Dividend Yield 0.57%
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP12.53%
Div Incr Years17
Div Non Decr Years22
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.28%
Min EPS beat(2)-10.06%
Max EPS beat(2)5.5%
EPS beat(4)1
Avg EPS beat(4)-5.64%
Min EPS beat(4)-15.11%
Max EPS beat(4)5.5%
EPS beat(8)2
Avg EPS beat(8)-3.57%
EPS beat(12)4
Avg EPS beat(12)-2.58%
EPS beat(16)7
Avg EPS beat(16)-1.87%
Revenue beat(2)1
Avg Revenue beat(2)-1.89%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)0.18%
Revenue beat(4)1
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)0.18%
Revenue beat(8)1
Avg Revenue beat(8)-1.44%
Revenue beat(12)2
Avg Revenue beat(12)-1.37%
Revenue beat(16)3
Avg Revenue beat(16)-1.23%
PT rev (1m)-20.25%
PT rev (3m)-22.86%
EPS NQ rev (1m)-0.66%
EPS NQ rev (3m)-11.53%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-6.29%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.28%
Valuation
Industry RankSector Rank
PE 19.56
Fwd PE 15.72
P/S 2.43
P/FCF 16.38
P/OCF 13.92
P/B 7.28
P/tB 77.13
EV/EBITDA 15.12
EPS(TTM)21.61
EY5.11%
EPS(NY)26.89
Fwd EY6.36%
FCF(TTM)25.81
FCFY6.11%
OCF(TTM)30.37
OCFY7.19%
SpS173.89
BVpS58.04
TBVpS5.48
PEG (NY)1.67
PEG (5Y)5.42
Graham Number167.993 (-60.26%)
Profitability
Industry RankSector Rank
ROA 16.91%
ROE 30.64%
ROCE 28.64%
ROIC 21.5%
ROICexc 21.8%
ROICexgc 60.78%
OM 13.69%
PM (TTM) 10.23%
GM 32.38%
FCFM 14.84%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score5
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.24
Debt/EBITDA 0.22
Cap/Depr 101.42%
Cap/Sales 2.62%
Interest Coverage 250
Cash Conversion 107.32%
Profit Quality 145.17%
Current Ratio 0.85
Quick Ratio 0.83
Altman-Z 10.5
F-Score5
WACC8.96%
ROIC/WACC2.4
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.32%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%0.36%
EPS Next Y11.69%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)2.07%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%1.63%
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A
EBIT growth 1Y-15.9%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.06%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y24.72%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y25.23%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%

CHEMED CORP / CHE Fundamental Analysis FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 6 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


What is the profitability of CHE stock?

CHEMED CORP (CHE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CHE stock?

The Price/Earnings (PE) ratio for CHEMED CORP (CHE) is 19.56 and the Price/Book (PB) ratio is 7.28.


What is the financial health of CHEMED CORP (CHE) stock?

The financial health rating of CHEMED CORP (CHE) is 7 / 10.